サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1425590

静注用免疫グロブリンの世界市場レポート 2024年

Intravenous Immunoglobulin Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
静注用免疫グロブリンの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

静注用免疫グロブリン市場規模は近年力強く成長しています。2023年の138億2,000万米ドルから2024年には148億4,000万米ドルへと、CAGR7.3％で拡大します。この期間の成長は、原発性免疫不全症や神経疾患の治療の進歩、高齢者人口の増加、血漿分画技術の向上、神経学分野での応用拡大、感染症治療、小児免疫不全症治療などに起因しています。

2023年の静注用免疫グロブリン市場で最大の地域は北米でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。静注用免疫グロブリン市場レポート対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の静注用免疫グロブリン市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 実績：市場規模と成長（2018年～2023年）
  • 予測：市場規模と成長（2023年～2028年、2033年）

第6章 市場セグメンテーション

  • 世界の静注用免疫グロブリン市場：タイプ別 - 実績および予測（2018年～2023年、2023年～2028年、2033年）
  • IgG（免疫グロブリンG）
  • IgM（免疫グロブリンM）
  • IgA（免疫グロブリンA）
  • IgE（免疫グロブリンE）
  • IgD（免疫グロブリンD）
  • 世界の静注用免疫グロブリン市場：流通チャネル別 - 実績および予測（2018年～2023年、2023年～2028年、2033年）
  • 病院薬局
  • 小売薬局
  • その他の流通チャネル
  • 世界の静注用免疫グロブリン市場：用途別 - 実績および予測（2018年～2023年、2023年～2028年、2033年）
  • 低ガンマグロブリン血症
  • 慢性炎症性脱髄性多発神経障害（CIDP）
  • 原発性免疫不全疾患
  • 重症筋無力症
  • 多巣性運動神経障害
  • その他の用途
  • 世界の静注用免疫グロブリン市場：エンドユーザー別 - 実績および予測（2018年～2023年、2023年～2028年、2033年）
  • 病院
  • クリニック
  • 在宅ケア

第7章 地域別・国別の分析

  • 世界の静注用免疫グロブリン市場：地域別 - 実績および予測（2018年～2023年、2023年～2028年、2033年）
  • 世界の静注用免疫グロブリン市場：国別 - 実績および予測（2018年～2023年、2023年～2028年、2033年）

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Bio Products Laboratory Limited
    • Biotest AG
    • China Biologic Products Holdings Inc.
    • CSL Behring
    • Grifols SA

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12821

Intravenous Immunoglobulin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous immunoglobulin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous immunoglobulin? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous immunoglobulin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: IgG (Immunoglobulin G); IgM (Immunoglobulin M); IgA (Immunoglobulin A); IgE (Immunoglobulin E); IgD (Immunoglobulin D)
  • 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
  • 3) By Application: Hypogammaglobulinemia; Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Primary Immunodeficiency Diseases; Myasthenia Gravis; Multifocal Motor Neuropathy; Other Applications
  • 4) By End-User: Hospitals; Clinics; Home Care
  • Companies Mentioned: Bio Products Laboratory Limited; Biotest AG; China Biologic Products Holdings Inc.; CSL Behring; Grifols S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Intravenous immunoglobulin therapy serves as a treatment for individuals with immunodeficiencies, administered through intravenous infusion. The infusion liquid derives from purified immunoglobulins sourced from healthy donors, rigorously cleansed to eliminate any potential blood-borne infections or impurities.

Key categories of intravenous immunoglobulins encompass IgG, IgM, IgA, IgE, and IgD. IgG, the prevalent immunoglobulin in bodily fluids, plays a pivotal role in safeguarding against bacterial and viral infections. Its application involves reinforcing the body's innate defense mechanisms. These products find distribution channels across hospital and retail pharmacies, serving various medical needs like hypogammaglobulinemia, CIDP, primary immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, among others. The end-users span hospitals, clinics, and home care setups.

The intravenous immunoglobulin market research report is one of a series of new reports from The Business Research Company that provides intravenous immunoglobulin market statistics, including intravenous immunoglobulin industry global market size, regional shares, competitors with an intravenous immunoglobulin market share, detailed intravenous immunoglobulin market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous immunoglobulin industry. This intravenous immunoglobulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous immunoglobulin market size has grown strongly in recent years. It will grow from $13.82 billion in 2023 to $14.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historical period can be credited to advancements in treating primary immunodeficiency disorders and neurological conditions, a growing elderly population, improved plasma fractionation techniques, widened applications in neurology, treatments for infectious diseases, and pediatric immunodeficiency therapies.

The intravenous immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $20.24 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The anticipated growth in the upcoming period is driven by the escalating occurrence of autoimmune disorders, continuous advancements in immunology research, higher healthcare spending, the rise in cancer cases, innovative developments in immunoglobulin products, and the adoption of personalized medicine strategies. Key trends expected in the forecast period encompass the treatment of primary immunodeficiency disorders (PIDD), swift technological progress, strategic partnerships and collaborations, enhancements in manufacturing techniques, expanded applications in neurology and hematology, and progressions in immunotherapy.

The advancing segment of the elderly population stands poised to propel the intravenous immunoglobulin market. As individuals surpass 65 years, their immune systems often falter, necessitating supplemental immunoglobulins due to declining antibody production. This surge in demand is evident, exemplified by projections in India where the elderly count surged from 138 million in 2021 to an anticipated 194 million by 2031. Likewise, the World Health Organization anticipates a global rise, estimating 1.4 billion people above 60 years by 2030, a significant climb from 1 billion in 2020. This demographic shift distinctly augments the intravenous immunoglobulin market.

The escalating prevalence of rheumatoid arthritis (RA) forecasts substantial growth in the intravenous immunoglobulin (IVIG) market. RA, a chronic autoimmune ailment impacting joints, triggers inflammation and potential joint deterioration. IVIG, derived from healthy donors, presents a remedy by obstructing the inflammatory process in RA. Illustratively, estimations from the Australian Institute of Health and Welfare in June 2023 project 456,000 Australians afflicted by RA, constituting 2.0% of the total disease burden and 16% of musculoskeletal conditions in 2022. Similarly, data from the National Rheumatoid Arthritis Society in July 2022 indicates over 450,000 individuals in the UK grappling with RA. The rising prevalence of RA delineates a significant driver for the IVIG market.

Product innovation emerges as a pivotal trend shaping the intravenous immunoglobulin market landscape. Key market players prioritize novel offerings, exemplified by Octapharma's June 2021 announcement of 'Octagam 10%,' a pioneering human plasma-derived IVIg endorsed by the European Union for treating dermatomyositis in adults. This breakthrough addresses a rare autoimmune disorder, marking a stride in therapeutic advancement and improved patient outcomes.

Strategic focus on pioneering products like PANZYGA characterizes major companies in the intravenous immunoglobulin market. Notably, in February 2021, Pfizer Inc. achieved FDA approval for PANZYGA, specifically for adults combating chronic inflammatory demyelinating polyneuropathy (CIDP). This marked the first FDA-endorsed IVIG with dual maintenance dosing options, catering to the diverse needs of CIDP patients. Grounded on comprehensive Phase 3 trials involving 142 individuals, this milestone offers healthcare providers flexibility in selecting appropriate dosages, addressing an unmet medical need in CIDP treatment.

In March 2021, Grifols SA, a leading Spanish pharmaceutical and chemical manufacturer, finalized the acquisition of GigaGen Inc for $115 million. This acquisition occurred in two phases such as initially, Grifols secured a 44% ownership for $35 million, followed by the acquisition of the remaining 56% stake for $80 million. This strategic move aligns with Grifols' overarching R+D+I (research, development, and innovation) strategy, aimed at fostering innovation and conducting research that complements its core business operations. GigaGen, a biotechnology firm based in the United States, specializes in pioneering the development and discovery of recombinant biotherapeutic medications.

Major companies operating in the intravenous immunoglobulin market report are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bayer AG, LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., Emergent BioSolutions Inc., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.

North America was the largest region in the intravenous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous immunoglobulin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravenous immunoglobulin market consists of sales of intravenous immunoglobulin used for treating people with antibody deficiencies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Intravenous Immunoglobulin Market Characteristics

3. Intravenous Immunoglobulin Market Trends And Strategies

4. Intravenous Immunoglobulin Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Intravenous Immunoglobulin Market Size and Growth

  • 5.1. Global Intravenous Immunoglobulin Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Intravenous Immunoglobulin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Intravenous Immunoglobulin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Intravenous Immunoglobulin Market Segmentation

  • 6.1. Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • IgG (Immunoglobulin G)
  • IgM (Immunoglobulin M)
  • IgA (Immunoglobulin A)
  • IgE (Immunoglobulin E)
  • IgD (Immunoglobulin D)
  • 6.2. Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other Distribution Channels
  • 6.3. Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hypogammaglobulinemia
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Primary Immunodeficiency Diseases
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • Other Applications
  • 6.4. Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Care

7. Intravenous Immunoglobulin Market Regional And Country Analysis

  • 7.1. Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Intravenous Immunoglobulin Market

  • 8.1. Asia-Pacific Intravenous Immunoglobulin Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Intravenous Immunoglobulin Market

  • 9.1. China Intravenous Immunoglobulin Market Overview
  • 9.2. China Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Intravenous Immunoglobulin Market

  • 10.1. India Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Intravenous Immunoglobulin Market

  • 11.1. Japan Intravenous Immunoglobulin Market Overview
  • 11.2. Japan Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Intravenous Immunoglobulin Market

  • 12.1. Australia Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Intravenous Immunoglobulin Market

  • 13.1. Indonesia Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Intravenous Immunoglobulin Market

  • 14.1. South Korea Intravenous Immunoglobulin Market Overview
  • 14.2. South Korea Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Intravenous Immunoglobulin Market

  • 15.1. Western Europe Intravenous Immunoglobulin Market Overview
  • 15.2. Western Europe Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Intravenous Immunoglobulin Market

  • 16.1. UK Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Intravenous Immunoglobulin Market

  • 17.1. Germany Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Intravenous Immunoglobulin Market

  • 18.1. France Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Intravenous Immunoglobulin Market

  • 19.1. Italy Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Intravenous Immunoglobulin Market

  • 20.1. Spain Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Intravenous Immunoglobulin Market

  • 21.1. Eastern Europe Intravenous Immunoglobulin Market Overview
  • 21.2. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Intravenous Immunoglobulin Market

  • 22.1. Russia Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Intravenous Immunoglobulin Market

  • 23.1. North America Intravenous Immunoglobulin Market Overview
  • 23.2. North America Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Intravenous Immunoglobulin Market

  • 24.1. USA Intravenous Immunoglobulin Market Overview
  • 24.2. USA Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Intravenous Immunoglobulin Market

  • 25.1. Canada Intravenous Immunoglobulin Market Overview
  • 25.2. Canada Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Intravenous Immunoglobulin Market

  • 26.1. South America Intravenous Immunoglobulin Market Overview
  • 26.2. South America Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Intravenous Immunoglobulin Market

  • 27.1. Brazil Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Intravenous Immunoglobulin Market

  • 28.1. Middle East Intravenous Immunoglobulin Market Overview
  • 28.2. Middle East Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Intravenous Immunoglobulin Market

  • 29.1. Africa Intravenous Immunoglobulin Market Overview
  • 29.2. Africa Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Intravenous Immunoglobulin Market Competitive Landscape And Company Profiles

  • 30.1. Intravenous Immunoglobulin Market Competitive Landscape
  • 30.2. Intravenous Immunoglobulin Market Company Profiles
    • 30.2.1. Bio Products Laboratory Limited
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Biotest AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. China Biologic Products Holdings Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. CSL Behring
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Grifols S.A.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Intravenous Immunoglobulin Market Competitive Benchmarking

32. Global Intravenous Immunoglobulin Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Intravenous Immunoglobulin Market

34. Intravenous Immunoglobulin Market Future Outlook and Potential Analysis

  • 34.1 Intravenous Immunoglobulin Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Intravenous Immunoglobulin Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Intravenous Immunoglobulin Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer